Miami Indian Community - MiamiIndian.net
| | | | | | | | | | | |
 


 

USFDA approves Granules' drug for migraine

Andhra Pradesh,Business/Economy,Health/Medicine

Author : Indo Asian News Service

Business/Economy, Health/Medicine, Andhra Pradesh, India Read Latest News and Articles

Share With Your Friends



Add an Article

View All Contributions

Add To My Favorite

Add A Picture

Hyderabad, Feb 24 (IANS) Granules India Ltd on Wednesday announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for acetaminophen, aspirin, and caffeine tablets, indicated for the treatment of migraine.

It is bioequivalent to the Reference Listed Drug (RLD) product, Excedrin Migraine tablets, 250 mg/250 mg/65 mg, of GlaxoSmithKline Consumer Healthcare.

The product would be manufactured at Granules India's Hyderabad facility and is expected to be launched shortly.

"We are pleased to announce approval of Acetaminophen, Aspirin and Caffeine tablets, emphasising our focus on building a sustainable OTC product portfolio in the US market. We received approval for this triple combination product within 14 months from filing. With this, we have received three ANDA approvals over the past month." said Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals, Inc.

Granules now has a total of 38 ANDA approvals from US FDA (37 Final approvals and 1 tentative approval). Excedrin is a trademark of GSK Consumer Healthcare S.A.

--IANS

ms/vd


Copyright and Disclaimer: All news and images appearing in our news section, search engines and social media are provided by IANS. If you face any issues related to the content/images, please contact our news service provider directly. We are not liable/responsible for any content/images related to the news service provider.


Latest News

View More News


More News Articles

IPL 2024: Every game is important; this is a very important stage of the tournament, says Ganguly

Moody feels Pant ahead in keepers' race for T20 WC squad; Srikkanth picks Rahul over Samson as reserve keeper

IPL 2024: RCB assistant coach credits Faf's decision to bat first for morale-boosting win vs SRH

IPL 2024: I would like to see Shivam Dube in the Indian T20 WC squad, says Yuvraj Singh

Anoushka Shankar to get honorary degree by Oxford University, calls it 'pinch-me moment'